Point72 (Difc) LTD Tenaya Therapeutics, Inc. Transaction History
Point72 (Difc) LTD
- $2.64 Trillion
- Q2 2025
A detailed history of Point72 (Difc) LTD transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 756 shares of TNYA stock, worth $1,224. This represents 0.0% of its overall portfolio holdings.
Number of Shares
756
Previous 11,028
93.14%
Holding current value
$1,224
Previous $6.29 Million
92.65%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TNYA
# of Institutions
94Shares Held
37MCall Options Held
91.4KPut Options Held
50.3K-
Column Group LLC San Francisco, CA9.4MShares$15.2 Million8.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.76MShares$7.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$6.6 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.26MShares$3.66 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.84MShares$2.99 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $67M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...